Medicinal cannabis CEO looking to raise money and ethical standards
Subscribe to BusinessDesk
Stay informed on business, government and financial developments across New Zealand.
- Deeply researched, twice-edited and fact-checked news
- Annual subscribers also receive a complimentary subscription to The Wall Street Journal
- Personalised email news alerts, plus gift up to 5 stories a month to non-subscribers
You can cancel anytime with two clicks, an email or a phone call.
Find out more.
We are serious about journalism.
Already a Subscriber ? Sign in here.
All subscriptions auto renew but are easy to cancel.
Total Price Including Tax: {{ priceWithTax(selectedPlan) | currency }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerSeat ? '/ '+ spark.seatName : '' }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerTeam ? '/ '+ __('teams.team') : '' }} / {{ __(selectedPlan.interval) | capitalize }}
Not convinced yet?
Subscribe to our free 7am Headlines newsletter.
A quick summary of everything BusinessDesk has published in the previous 24 hours. No BusinessDesk
subscription needed.
Hallenstein stars as NZ stocks drift lower
The S&P/NZX 50 Index was 42.06 points or 0.32% lower at 13,111.73.
Trump to slap new tariffs on pharma
Levies on drugs will be imposed on companies that aren’t building plants in the US.
Billions in play: Major projects await pre-Christmas go-ahead
Minister Chris Bishop expects eight more fast-track approval decisions before Christmas.
AI agents: opportunity or graveyard? Spark’s five-point playbook for success
Artificial intelligence agents – autonomous digital entities that analyse data, automate decisions, and act independently – are set to drive a new wave of business transformation.
Future leaders start by Dreaming Big
How OnBeingBold empowers Year 13 girls at free leadership events.
